- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Lee Newcomer Discusses Payer Strategies in Population Health Management
Social determinants of health are being carefully tended to in the Medicare populations, explained Lee Newcomer, MD, MHA, private consultant.
Social determinants of health are being carefully tended to in the Medicare populations, explained Lee Newcomer, MD, MHA, private consultant.
Transcript
Do payer strategies include using social and behavioral determinants of health (SBDH) in population health management?
Well here I’m speaking broadly, but yes, they do make a difference. I think where you see social determinants being really carefully tended to is in the Medicaid populations. Almost every payer in the Medicaid space is helping to provide transportation or maybe even childcare—sometimes even as far as housing because it’s clear that those issues have to be addressed if the healthcare is going to be addressed.
There are models out in the United States across the entire country where people are trying to add social determinants to make the healthcare better.
Can value-based models incentivize consideration of social and behavioral determinants of health?
I think they actually can, but again the ultimate objective is 'how do I get my patient healthy, and how can I do it for the least amount of money.' So, if social determinants help then they will be addressed. But if they aren’t going to make a difference, then they probably won’t be addressed. That’s why I come back to the Medicaid population—I think that’s the group that’s gotten, by far in a way, the best benefit from working on social determinants.
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More
The Biden administration recently launched the Global Health Security Strategy, a new effort to combat the spread of infectious diseases; lawmakers zeroed in on the risks of massive consolidation in health care during the first congressional hearing on the Change Healthcare hack; the FDA recently announced the recall of a pair of heart devices linked to numerous deaths and injuries.
Read More
